• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cost Eff Resour Alloc . The FLURESP European commission project: cost-effectiveness assessment of ten public health measures against influenza in It

tetano

Editor, Senior Moderator
Cost Eff Resour Alloc


. 2023 May 15;21(1):30.
doi: 10.1186/s12962-023-00432-0. The FLURESP European commission project: cost-effectiveness assessment of ten public health measures against influenza in Italy: is there an interest in COVID-19 pandemic?

Ariel Beresniak[SUP] 1 [/SUP], Christian Napoli[SUP] 2 [/SUP], John Oxford[SUP] 3 [/SUP], Alejandra Daruich[SUP] 4 5 [/SUP], Laurent Niddam[SUP] 6 [/SUP], Gérard Duru[SUP] 7 [/SUP], Alberto E Tozzi[SUP] 8 [/SUP], Marta Ciofi Degli Atti[SUP] 8 [/SUP], Danielle Dupont[SUP] 7 [/SUP], Caterina Rizzo[SUP] #[/SUP][SUP] 8 [/SUP], Dominique Bremond-Gignac[SUP] #[/SUP][SUP] 4 5 [/SUP]



Affiliations
Abstract

Background: The FLURESP project is a public health research funded by the European Commission, with the objective to design a methodological framework to assess the cost-effectiveness of existing public health measures against human influenza pandemics. A dataset has been specifically collected in the frame of the Italian health system. As most of interventions against human influenza are relavant against other respiratory diseases pandemics, potential interests in COVID-19 are discussed.
Methods: Ten public health measures against human influenza pandemics pandemic were selected to be also relevant to other respiratory virus pandemics such as COVID 19: individual (hand washing, using masks), border control (quarantine, fever screening, border closure), community infection (school closure, class dismissal, social distancing, limitation of public transport), reduction of secondary infections (implementation of antibiotic therapy guidelines), pneumococcal vaccination for at-risk people, development of Intensive Care Unit (ICU) capacity, implementation of life support equipments in ICU, screening interventions, vaccination programs targeting health professional and targeting general population.
Results: Using mortality reduction as effectiveness criteria, the most cost-effective strategies are "reduction of secondary infections" and "implementation of life support equipment in ICU". The least cost-effective option whatever the level of pandemic events are screening interventions and mass vaccination.
Conclusions: A number of intervention strategies against human influenza pandemics appears relevant against every respiratory virus, including the COVID-19 event. Measures against pandemics should be considered according to their expected effectiveness but also their costs for the society because they impose substantial burden to the population, confirming the interest of considering cost-effectiveness of public health measures to enlighten decision making.

Keywords: COVID-19; Cost-Effectiveness; Emergency preparedness; Human influenza; Pandemics; SARS-CoV-2.

 
Back
Top Bottom